Rayont Inc. Share Price

Equities

RAYT

US75508M1009

Biotechnology & Medical Research

Market Closed - OTC Markets 16:09:38 30/04/2024 BST 5-day change 1st Jan Change
0.1 USD +19,900.00% Intraday chart for Rayont Inc. -.--% +1,000,000.00%
Sales 2021 2.97M 237M Sales 2022 2.84M 227M Capitalization 45.69M 3.65B
Net income 2021 - 0 Net income 2022 - 0 EV / Sales 2021 47.8 x
Net Debt 2021 2.4M 192M Net Debt 2022 7.78M 621M EV / Sales 2022 18.8 x
P/E ratio 2021
293 x
P/E ratio 2022
186 x
Employees 58
Yield 2021 *
-
Yield 2022
-
Free-Float 48.18%
More Fundamentals * Assessed data
Dynamic Chart
1 day+19,900.00%
1 month+19,900.00%
3 months+19,900.00%
More quotes
1 month
0.00
Extreme 0.0005
0.10
Current year
0.00
Extreme 0.0005
0.10
1 year
0.00
Extreme 0
0.70
3 years
0.00
Extreme 0
3.02
5 years
0.00
Extreme 0
3.02
10 years
0.00
Extreme 0
10.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 30/03/20
Chief Operating Officer - 15/05/22
Director/Board Member 48 24/03/21
Members of the board TitleAgeSince
Director/Board Member 52 20/04/22
Director/Board Member 48 24/03/21
Chief Executive Officer 48 30/03/20
More insiders
Date Price Change Volume

Delayed Quote OTC Markets, April 30, 2024 at 04:09 pm

More quotes
Rayont Inc. operates in the personalized natural healthcare sector in United States and Australia. The Company uses scientific tools, such as deoxyribonucleic acid (DNA), microbiome, iridology and other tests to diagnose and personalize the prescription of natural complementary medicine products, services and treatments to its patients in the markets the Company operate. The Company produces a range of products, including proteins, green blends, sports nutrition, weight management and maintenance, and health and wellness products. The Company's subsidiaries include Rayont (Malaysia) Sdn Bhd, Rayont International (L) Limited, Rayont (Australia) Pty Ltd and Prema Life (USA) Inc.
More about the company